These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34838650)

  • 1. Development of isoquinolinone derivatives as immunoproteasome inhibitors.
    Ettari R; Iraci N; Di Chio C; Previti S; Danzè M; Zappalà M
    Bioorg Med Chem Lett; 2022 Jan; 55():128478. PubMed ID: 34838650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.
    Maccari R; Ettari R; Adornato I; Naß A; Wolber G; Bitto A; Mannino F; Aliquò F; Bruno G; Nicolò F; Previti S; Grasso S; Zappalà M; Ottanà R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):278-283. PubMed ID: 29292224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Amides as Noncovalent Inhibitors of Immunoproteasomes.
    Ettari R; Cerchia C; Maiorana S; Guccione M; Novellino E; Bitto A; Grasso S; Lavecchia A; Zappalà M
    ChemMedChem; 2019 Apr; 14(8):842-852. PubMed ID: 30829448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of peptide epoxyketones as selective immunoproteasome inhibitors.
    Li X; Hong D; Zhang M; Xu L; Zhou Y; Li J; Liu T
    Eur J Med Chem; 2021 Oct; 221():113556. PubMed ID: 34087498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
    de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
    J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.
    Culletta G; Tutone M; Ettari R; Perricone U; Di Chio C; Almerico AM; Zappalà M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.
    Kollár L; Gobec M; Proj M; Smrdel L; Knez D; Imre T; Gömöry Á; Petri L; Ábrányi-Balogh P; Csányi D; Ferenczy GG; Gobec S; Sosič I; Keserű GM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors.
    Nan G; Huang L; Li Y; Yang Y; Yang Y; Li K; Lai F; Chen X; Xiao Z
    Eur J Med Chem; 2022 Apr; 234():114252. PubMed ID: 35286927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.
    Singh PK; Fan H; Jiang X; Shi L; Nathan CF; Lin G
    ChemMedChem; 2016 Oct; 11(19):2127-2131. PubMed ID: 27561172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.
    Maurits E; Degeling CG; Kisselev AF; Florea BI; Overkleeft HS
    Chembiochem; 2020 Nov; 21(22):3220-3224. PubMed ID: 32598532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argyrin B, a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i.
    Allardyce DJ; Bell CM; Loizidou EZ
    Chem Biol Drug Des; 2019 Aug; 94(2):1556-1567. PubMed ID: 31074944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor.
    Arai Y; Shitama H; Yamagishi M; Ono S; Kashima A; Hiraizumi M; Tsuda N; Katayama K; Tanaka K; Koda Y; Kato S; Sakata K; Nureki O; Miyazaki H
    Bioorg Med Chem; 2024 Jul; 109():117790. PubMed ID: 38906067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells.
    Ettari R; Pallio G; Pizzino G; Irrera N; Zappalà M; Maiorana S; Di Chio C; Altavilla D; Squadrito F; Bitto A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1307-1313. PubMed ID: 31307247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors.
    Yang Y; Wang K; Wu B; Yang Y; Lai F; Chen X; Xiao Z
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127508. PubMed ID: 32853683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes.
    Xin BT; de Bruin G; Huber EM; Besse A; Florea BI; Filippov DV; van der Marel GA; Kisselev AF; van der Stelt M; Driessen C; Groll M; Overkleeft HS
    J Med Chem; 2016 Aug; 59(15):7177-87. PubMed ID: 27438186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptidomimetic boronates as proteasome inhibitors.
    Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
    Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening.
    Kasam V; Lee NR; Kim KB; Zhan CG
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3614-7. PubMed ID: 24913713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors.
    Schiffrer ES; Proj M; Gobec M; Rejc L; Šterman A; Mravljak J; Gobec S; Sosič I
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).
    Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O
    J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.